CLINICAL_TRIALS
trial_result
· 2022-05-17
Clinical Trial Update: Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease [Phase 4]
Summary
Phase 4 trial evaluating whether regular cognitive exercises contribute to treatment effects in Alzheimer's disease patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: Alzheimer Disease, Cognitive Change | Phase 4 | Status: UNKNOWN